A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

ClinicalTrials.gov ID: NCT06313593

Public ClinicalTrials.gov record NCT06313593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 16, 2026, 3:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms

Study identification

NCT ID: NCT06313593
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Incyte Corporation; Industry
Enrollment: 186 participants

Conditions and interventions

Conditions

Myeloproliferative Neoplasms

Interventions

INCB160058 Drug
Standard disease-directed therapy Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 7, 2024
Primary completion: Oct 8, 2028
Completion: Oct 8, 2028
Last update posted: May 3, 2026

2024 – 2028

United States locations

U.S. sites: 13
U.S. states: 11
U.S. cities: 11

Facility	City	State	ZIP	Site status
The University of Alabama At Birmingham	Birmingham	Alabama	35249	Recruiting
Stanford University	Palo Alto	California	94304	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Northwestern University	Chicago	Illinois	60611	Recruiting
The University of Kansas Cancer Center Kucc University of Kansas Clinical Research Center	Fairway	Kansas	66205	Recruiting
University of Michigan	Ann Arbor	Michigan	48109-5008	Recruiting
Cornell Medical Center	New York	New York	10021	Recruiting
Icahn School of Medicine At Mount Sinai	New York	New York	10029	Recruiting
Sloan Kettering Institute For Cancer Research	New York	New York	10065	Recruiting
Oregon Health & Science University	Portland	Oregon	97239	Recruiting
University of Pennsylvania Health System	Philadelphia	Pennsylvania	19104	Recruiting
Vanderbilt-Ingram Cancer Center	Nashville	Tennessee	37232	Recruiting
Md Anderson Cancer Center	Houston	Texas	77030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06313593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 3, 2026 · Synced May 16, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06313593 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →